Literature DB >> 229647

Severe neutropenia in infectious mononucleosis.

W P Hammond, J M Harlan, S E Steinberg.   

Abstract

Mild neutropenia is a well-known concomitant of infectious mononucleosis caused by the Epstein-Barr virus (EBV) occurring in the first weeks of illness. However, severe neutropenia (less than 200 polymorphonuclear leukocytes per mul) is not generally regarded as a complication of infectious mononucleosis. Three patients were seen with severe neutropenia and EBV infection, and an additional eight cases were found in the literature. In two of the latter cases the neutropenia was fatal. In the 11 cases the severe neutropenia began 14 to 40 days after illness and usually lasted for three to seven days. At the time of severe neutropenia, studies of marrow specimens showed increased proportions of promyelocytes and myelocytes. Our data suggest that EBV infection is the proximate cause of the severe neutropenia in some patients with infectious mononucleosis and that in such cases close observation and early treatment of suspected superinfections is necessary.

Entities:  

Mesh:

Year:  1979        PMID: 229647      PMCID: PMC1271698     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  22 in total

1.  Infectious mononucleosis; a study of 210 sporadic cases.

Authors:  J E STEVENS; E D BAYRD; F J HECK
Journal:  Am J Med       Date:  1951-08       Impact factor: 4.965

2.  Heterophil-negative infectious mononucleosis and mononucleosis-like illnesses. Laboratory confirmation of 43 cases.

Authors:  C A Horwitz; W Henle; G Henle; H Polesky; H H Balfour; R A Siem; S Borken; P C Ward
Journal:  Am J Med       Date:  1977-12       Impact factor: 4.965

3.  Opportunistic non-Hodgkin's lymphoma in X-linked recessive immunodeficiency and lymphoproliferative syndromes.

Authors:  D T Purtilo
Journal:  Semin Oncol       Date:  1977-09       Impact factor: 4.929

4.  Fatal infectious mononucleosis in a family.

Authors:  R S Bar; C J DeLor; K P Clausen; P Hurtubise; W Henle; J F Hewetson
Journal:  N Engl J Med       Date:  1974-02-14       Impact factor: 91.245

5.  Granulocyte changes in infectious mononucleosis.

Authors:  R L Carter
Journal:  J Clin Pathol       Date:  1966-05       Impact factor: 3.411

6.  Complications of infectious mononucleosis. A fatal case in a 2-year-old child.

Authors:  J M Dorman; T H Glick; D C Shannon; J Galdabini; A Walker
Journal:  Am J Dis Child       Date:  1974-08

7.  [Infectious mononucleosis and Guillain-Barre syndrome].

Authors:  J Leng-Lévy; R Castaing; J Aubertin; B Leng; J Marion; J Y Lacut; P Lardeau
Journal:  Bord Med       Date:  1970-09

8.  Pathogenesis and phenotypes of an X-linked recessive lymphoproliferative syndrome.

Authors:  D T Purtilo
Journal:  Lancet       Date:  1976-10-23       Impact factor: 79.321

9.  Variable phenotypic expression of an X-linked recessive lymphoproliferative syndrome.

Authors:  D T Purtilo; D DeFlorio; L M Hutt; J Bhawan; J P Yang; R Otto; W Edwards
Journal:  N Engl J Med       Date:  1977-11-17       Impact factor: 91.245

10.  X-linked recessive progressive combined variable immunodeficiency (Duncan's disease).

Authors:  D T Purtilo; C K Cassel; J P Yang; R Harper
Journal:  Lancet       Date:  1975-04-26       Impact factor: 79.321

View more
  5 in total

1.  Increased susceptibility to bacterial superinfection as a consequence of innate antiviral responses.

Authors:  Alexander A Navarini; Mike Recher; Karl S Lang; Panco Georgiev; Susanne Meury; Andreas Bergthaler; Lukas Flatz; Jacques Bille; Regine Landmann; Bernhard Odermatt; Hans Hengartner; Rolf M Zinkernagel
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-09       Impact factor: 11.205

2.  High-dose dexamethasone therapy for severe thrombocytopenia and neutropenia induced by EBV infectious mononucleosis.

Authors:  Yuki Kagoya; Akira Hangaishi; Tsuyoshi Takahashi; Yoichi Imai; Mineo Kurokawa
Journal:  Int J Hematol       Date:  2010-03       Impact factor: 2.490

3.  Agranulocytosis following infectious mononucleosis.

Authors:  S Sumimoto; Y Kasajima; T Hamamoto; T Miyanomae; Y Iwai; M Mayumi; H Mikawa
Journal:  Eur J Pediatr       Date:  1990-07       Impact factor: 3.183

Review 4.  Exploiting the interplay between innate and adaptive immunity to improve immunotherapeutic strategies for Epstein-Barr-virus-driven disorders.

Authors:  Debora Martorelli; Elena Muraro; Anna Merlo; Riccardo Turrini; Damiana Antonia Faè; Antonio Rosato; Riccardo Dolcetti
Journal:  Clin Dev Immunol       Date:  2012-01-29

5.  Tree Shrew Is a Suitable Animal Model for the Study of Epstein Barr Virus.

Authors:  Wei Xia; Honglin Chen; Yiwei Feng; Nan Shi; Zongjian Huang; Qingyuan Feng; Xu Jiang; Guangyao He; Mao Xie; Yongjin Lai; Zhi Wang; Xiang Yi; Anzhou Tang
Journal:  Front Immunol       Date:  2022-01-17       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.